14th European AIDS Conference, 16-19 October 2013, Brussels, Belgium

Oral presentations

1 Infection related and unrelated malignancies, HIV and the aging population. L Shepherd on behalf of EuroSIDA in EuroCoord. presentation

2 The spectrum of clinical disease and relationship with measures of deteriorating renal function. A Mocroft on behalf of EuroSIDA in EuroCoord. presentation

3 Management of cardiovascular risk in HIV positive individuals in Europe. M Shahmanesh on behalf of EuroSIDA in EuroCoord presentation

4 Prevalence of detected drug resistance across different regions of Europe: Data from EuroSIDA 1997-2012. A Schultze on behalf of EuroSIDA in EuroCoord. presentation

5 Prognostic value of vitamin D level for all-cause mortality, and association with inflammatory markers in HIV-infected persons. JP Viard on behalf of EuroSIDA in EuroCoord. presentation

Poster presentations

1 Investigating the causal impact of PI- and NNRTI-containing cART on the risk of mortality: methodological challenges. C Smith et al. for the D:A:D Study Group. poster

2 Development of thrombocytopenia and risk of AIDS and serious non-AIDS events in Europe. AH Borges et al. on behalf of EuroSIDA in EuroCoord. poster

3 Estimation of percentage of HIV-infected people with limited future drug options in a closed observational setting over the period 2007-2011 and beyond. A Cozzi-Lepri et al. for EuroSIDA in EuroCoord. poster

4 Is Stavudine (D4T) still being used in EuroSIDA despite its association with toxicity and a higher frequency of sever adverse events. D Grint et al. for EuroSIDA in EuroCoord. poster

5 Prognostic value of vitamin D level for all-cause mortality, and association with inflammatory markers, in HIV-infected persons: results from the EuroSIDA cohort study. J-P Viard, et al. on behalf of EuroSIDA in EuroCoord. poster

6 Management of cardiovascular risk in HIV positive individuals in Europe. M Shahmanesh, et al. on behalf of EuroSIDA in EuroCoord. poster

7 A survey of ATRIPLA use in clinical practice among treatment-naïve HIV-positive patients in Europe. O Kirk et al. for EuroSIDA in EuroCoord. poster

13th International Workshop on HIV & Hepatitis Virus Drug Resistance and Curative Strategies, 4-8 June 2013, Toronto, Canada

Low-frequency drug-resistant HIV-1 and risk of virological failure to firts-line NNRTI-based ART: a multi-cohort European case-control study using centralized ultrasensitive 454 sequencing. A Cozzi-Lepri, M Noguera-Julian, F Di Giallonardo, R Schuurman, M Däumer, S Aitken, HF Günthard, F Brun-Vezinet, KJ Metzner, R Paredes, and the CHAIN Minority HIV-1 Variants Working Group.

20th Conference on Retroviruses and Opportunistic Infections, CROI 2013, 3-6 March 2013, Atlanta

Poster presentations

1 Increased Risk Of Antiretriviral Drug Discontuniation among Patienst with High Hyaluronic Acid, a Marker of Liver Fibrosis. D Grint, L Peters, J Rockstroh, JD Lundgren, S de Wit, VM Mitsura. B Knysz, C Pedersen, O Kirk, A Mocroft
poster

2 A comparison of estimated glomerular reates (eGFRs) using Cockcroft-Gault (CG) and the CKD-EPI estimating equations. A Mocroft, L Ryom, P Reiss, B Ledergerber, A Monforte, J Gatell, S de Wit, M beniowski, JD Lundgren and O Kirk for EuroSIDA in EuroCoord.
poster

11th European Meeting on HIV & Hepatitis, 20-22 March 2013, Rome, Italy

Oral presentations

1 Detection of Non-R5 HIV-1 by Ultrasensitive Genotypic Testing Is Associated with CD4+ Count Decreases Also After the Initiation of ART.
M Casadellà, A Cozzi-Lepri, A Phillips, M Noguera-Julian, M Bickel, D Duiculescu, K Zilmer, B Clotet, JD Lundgren, R Paredes for EuroSIDA in EuroCOORD

Poster presentations

1 Detection of non-R5 HIV by ultrasensitive genotypic testing is associated with CD4+ count decreases also after the initiation of ART. M Casadellà, A Cozzi-Lepri, A Phillips, M Noguera-Julian, M Bickel, D Duiculescu, K Zilmer, B Clotet, JD Lundgren, R Paredes for EuroSIDA in EuroCOORD
poster